PCSA Processa Pharmaceuticals
- 1.1550
- -0.1750-13.16%
- 1.1600
- +0.0050+0.43%
Processa Pharmaceuticals News
Processa Pharmaceuticals | 10-Q: Quarterly report
Processa Pharmaceuticals | 8-K: Current report
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Pannu Geraldine
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Yorke Justin W
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Neal James R
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Baluch Khoso
Processa Pharmaceuticals | 8-K: Current report
Processa Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bigora Sian
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stanker James H
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lin Patrick
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Young David
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Guy Wendy
Processa Pharmaceuticals | 8-K: Current report
Processa Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer SKIBSTED RUSSELL
Processa Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer SKIBSTED RUSSELL
Processa Pharmaceuticals | 8-K: Current report
Processa Pharmaceuticals | 8-K: Current report
Processa Pharmaceuticals | DEFR14A: Definitive proxy statement in connection with contested solicitations
Analysis
Price Target
No Data
No Data